StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) income statement

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.41+0.01 (+2.18%)

Close on Nov 18, 2026Market cap $82.86MP/E –Yield –

Lucid Diagnostics Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
-36.1%
Operating margin
-930.9%
Net margin
-959.8%
Return on equity, FY2025
-710.6%

Financial strength

Current ratio
1.33
Debt to equity
–
Debt to assets
–
Cash to current liabilities
121.4%

Valuation

P/E ratio
–
Price to sales
15.22
Price to book
7.58
Dividend yield
–

See a number that looks wrong?